Global Short Bowel Syndrome Market Insights, Forecast to 2025

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Short Bowel Syndrome Revenue
• 1.4 Market by Type
  • 1.4.1 Global Short Bowel Syndrome Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 GLP-2
  • 1.4.3 Growth Hormone
  • 1.4.4 Glutamine
  • 1.4.5 Others
• 1.5 Market by Application
  • 1.5.1 Global Short Bowel Syndrome Market Share by Application: 2020 VS 2026
  • 1.5.2 Hospitals
  • 1.5.3 Clinics
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global Short Bowel Syndrome Market Perspective (2015-2026)
• 2.2 Global Short Bowel Syndrome Growth Trends by Regions
  • 2.2.1 Short Bowel Syndrome Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Short Bowel Syndrome Historic Market Share by Regions (2015-2020)
  • 2.2.3 Short Bowel Syndrome Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Short Bowel Syndrome Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Short Bowel Syndrome Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Short Bowel Syndrome Players by Market Size
  • 3.1.1 Global Top Short Bowel Syndrome Players by Revenue (2015-2020)
  • 3.1.2 Global Short Bowel Syndrome Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Short Bowel Syndrome Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Short Bowel Syndrome Market Concentration Ratio
  • 3.2.1 Global Short Bowel Syndrome Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Short Bowel Syndrome Revenue in 2019
• 3.3 Short Bowel Syndrome Key Players Head office and Area Served
• 3.4 Key Players Short Bowel Syndrome Product Solution and Service
• 3.5 Date of Enter into Short Bowel Syndrome Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Short Bowel Syndrome Historic Market Size by Type (2015-2020)
• 4.2 Global Short Bowel Syndrome Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global Short Bowel Syndrome Market Size by Application (2015-2020)
• 5.2 Global Short Bowel Syndrome Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Short Bowel Syndrome Market Size (2015-2020)
• 6.2 Short Bowel Syndrome Key Players in North America (2019-2020)
• 6.3 North America Short Bowel Syndrome Market Size by Type (2015-2020)
• 6.4 North America Short Bowel Syndrome Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Short Bowel Syndrome Market Size (2015-2020)
• 7.2 Short Bowel Syndrome Key Players in Europe (2019-2020)
• 7.3 Europe Short Bowel Syndrome Market Size by Type (2015-2020)
• 7.4 Europe Short Bowel Syndrome Market Size by Application (2015-2020)

8 China

• 8.1 China Short Bowel Syndrome Market Size (2015-2020)
• 8.2 Short Bowel Syndrome Key Players in China (2019-2020)
• 8.3 China Short Bowel Syndrome Market Size by Type (2015-2020)
• 8.4 China Short Bowel Syndrome Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Short Bowel Syndrome Market Size (2015-2020)
• 9.2 Short Bowel Syndrome Key Players in Japan (2019-2020)
• 9.3 Japan Short Bowel Syndrome Market Size by Type (2015-2020)
• 9.4 Japan Short Bowel Syndrome Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Short Bowel Syndrome Market Size (2015-2020)
• 10.2 Short Bowel Syndrome Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Short Bowel Syndrome Market Size by Type (2015-2020)
• 10.4 Southeast Asia Short Bowel Syndrome Market Size by Application (2015-2020)

11 India

• 11.1 India Short Bowel Syndrome Market Size (2015-2020)
• 11.2 Short Bowel Syndrome Key Players in India (2019-2020)
• 11.3 India Short Bowel Syndrome Market Size by Type (2015-2020)
• 11.4 India Short Bowel Syndrome Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Short Bowel Syndrome Market Size (2015-2020)
• 12.2 Short Bowel Syndrome Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Short Bowel Syndrome Market Size by Type (2015-2020)
• 12.4 Central & South America Short Bowel Syndrome Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Takeda
  • 13.1.1 Takeda Company Details
  • 13.1.2 Takeda Business Overview
  • 13.1.3 Takeda Short Bowel Syndrome Introduction
  • 13.1.4 Takeda Revenue in Short Bowel Syndrome Business (2015-2020))
  • 13.1.5 Takeda Recent Development
• 13.2 Merck
  • 13.2.1 Merck Company Details
  • 13.2.2 Merck Business Overview
  • 13.2.3 Merck Short Bowel Syndrome Introduction
  • 13.2.4 Merck Revenue in Short Bowel Syndrome Business (2015-2020)
  • 13.2.5 Merck Recent Development
• 13.3 Emmaus Life Sciences
  • 13.3.1 Emmaus Life Sciences Company Details
  • 13.3.2 Emmaus Life Sciences Business Overview
  • 13.3.3 Emmaus Life Sciences Short Bowel Syndrome Introduction
  • 13.3.4 Emmaus Life Sciences Revenue in Short Bowel Syndrome Business (2015-2020)
  • 13.3.5 Emmaus Life Sciences Recent Development
• 13.4 Nutrinia
  • 13.4.1 Nutrinia Company Details
  • 13.4.2 Nutrinia Business Overview
  • 13.4.3 Nutrinia Short Bowel Syndrome Introduction
  • 13.4.4 Nutrinia Revenue in Short Bowel Syndrome Business (2015-2020)
  • 13.4.5 Nutrinia Recent Development
• 13.5 GlyPharma Therapeutics
  • 13.5.1 GlyPharma Therapeutics Company Details
  • 13.5.2 GlyPharma Therapeutics Business Overview
  • 13.5.3 GlyPharma Therapeutics Short Bowel Syndrome Introduction
  • 13.5.4 GlyPharma Therapeutics Revenue in Short Bowel Syndrome Business (2015-2020)
  • 13.5.5 GlyPharma Therapeutics Recent Development
• 13.6 OxThera
  • 13.6.1 OxThera Company Details
  • 13.6.2 OxThera Business Overview
  • 13.6.3 OxThera Short Bowel Syndrome Introduction
  • 13.6.4 OxThera Revenue in Short Bowel Syndrome Business (2015-2020)
  • 13.6.5 OxThera Recent Development
• 13.7 Ardelyx
  • 13.7.1 Ardelyx Company Details
  • 13.7.2 Ardelyx Business Overview
  • 13.7.3 Ardelyx Short Bowel Syndrome Introduction
  • 13.7.4 Ardelyx Revenue in Short Bowel Syndrome Business (2015-2020)
  • 13.7.5 Ardelyx Recent Development
• 13.8 Sancilio & Company
  • 13.8.1 Sancilio & Company Company Details
  • 13.8.2 Sancilio & Company Business Overview
  • 13.8.3 Sancilio & Company Short Bowel Syndrome Introduction
  • 13.8.4 Sancilio & Company Revenue in Short Bowel Syndrome Business (2015-2020)
  • 13.8.5 Sancilio & Company Recent Development
• 13.9 Naia Pharmaceuticals
  • 13.9.1 Naia Pharmaceuticals Company Details
  • 13.9.2 Naia Pharmaceuticals Business Overview
  • 13.9.3 Naia Pharmaceuticals Short Bowel Syndrome Introduction
  • 13.9.4 Naia Pharmaceuticals Revenue in Short Bowel Syndrome Business (2015-2020)
  • 13.9.5 Naia Pharmaceuticals Recent Development
• 13.10 Zealand Pharma
  • 13.10.1 Zealand Pharma Company Details
  • 13.10.2 Zealand Pharma Business Overview
  • 13.10.3 Zealand Pharma Short Bowel Syndrome Introduction
  • 13.10.4 Zealand Pharma Revenue in Short Bowel Syndrome Business (2015-2020)
  • 13.10.5 Zealand Pharma Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer